纯合子家族性高胆固醇血症中的主动脉瓣狭窄:一个世纪以来的范式转变
本文系统综述了纯合子家族性高胆固醇血症(HoFH)患者中主动脉瓣狭窄(AS)的临床特征与演变,检索381篇文献后纳入19项横断面或回顾性研究及108例个案报告。在424例HoFH患者中,AS患病率在他汀前时代为57%,近期(>2000年长期他汀期)为35%;随着他汀和脂蛋白血浆置换延长生存,瓣上性主动脉瓣狭窄(SVAS)与瓣膜性主动脉瓣狭窄(VAS)的比例从他汀未治疗者的47:53转变为长期他汀治疗者的10:90。结论提示HoFH中AS常见,且表型向钙化性VAS转变。
要点
- HoFH患者中主动脉瓣狭窄常见,他汀前时代患病率57%,长期他汀期降至35%。
- 随他汀和脂蛋白血浆置换改善生存,AS表型从SVAS为主转向钙化性VAS为主。
- 长期他汀治疗者SVAS:VAS比例为10:90,未治疗者为47:53。
核心结论
- HoFH患者中SVAS和VAS均常见,随着他汀和脂蛋白血浆置换改善生存,AS表型向钙化性VAS转变。
主要发现
- 在424例HoFH患者中,AS患病率在他汀前时代为57%,近期(>2000年长期他汀期)为35%。
- 他汀未治疗者SVAS:VAS比例为47:53,长期他汀治疗者为10:90。
关键数值与推荐
- HoFH患者AS患病率:他汀前时代57%,近期(>2000年)35%。
- SVAS:VAS比例:他汀未治疗者47:53,长期他汀治疗者10:90。
临床怎么用
- 对HoFH患者应关注主动脉瓣狭窄,尤其是长期他汀治疗者以钙化性VAS为主。
- 他汀和脂蛋白血浆置换改善HoFH生存,但需监测AS表型变化。
局限性
- 纳入研究为横断面或回顾性设计,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Homozygous familial hypercholesterolaemia (HoFH) is an orphan disease defined by extreme elevations in low-density lipoprotein cholesterol, cutaneous xanthomas, and pre-mature atherosclerotic cardiovascular disease. Survival has more than doubled over the past three decades. Aortic stenosis (AS) [supravalvular aortic stenosis (SVAS) or valvular aortic stenosis (VAS)] is commonly encountered. There are no medical treatments available and complex high-risk surgeries represent the only available option in severe cases. A systematic review was performed to summarize the current evidence on AS in HoFH and to determine whether pharmacological treatment (statins) have had an impact on clinical presentation, phenotype and clinical course over the past nine decades (PROSPERO CRD42021250565). METHODS AND RESULTS: MEDLINE, Embase Classic + Embase, Cochrane Central Register of Controlled Trials, PubMed, AfricaWide, and Scopus were searched from inception to 10 November 2021. Searches identified 381 publications, of which 19 were retained; they were cross-sectional or retrospective studies. Separately, 108 individual case reports were described. Within the 424 HoFH cases, AS was identified in 57% of patients in the pre-statin era vs. 35% in patients reported more recently (>2000, long-term statin period). With an increase in longevity due to statins and lipoprotein apheresis, a change in the proportion of patients with SVAS and VAS with a SVAS:VAS ratio of 47:53 and 10:90 for HoFH patients not on statin and on long-term statin, respectively, was noted. CONCLUSION: These data suggest that SVAS and VAS are frequent in HoFH and that the phenotype has shifted towards calcific VAS as statins and lipoprotein apheresis improve survival in these patients.
引用
- Bélanger AM, Akioyamen LE, Ruel I, et al. Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century. Eur Heart J. 2022. PMID: 35776569. doi:10.1093/eurheartj/ehac339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。